Structural 12/14

Medstream360 members only

To view this video and learn more about the procedure please Login or Register.
Membership is free!

The Mount Sinai Hospital

1468 Madison Avenue, New York,
New York 10029

CoreValve TAVR (29mm) via Percutaneous Femoral Access

Core valve TAVR

An 84 year-old male presented with NYHA class III heart failure associated with progressive weakness and dyspnea. TTE revealed severe AS, peak/mean aortic gradient = 63/42 mmHg, AVA = 0.8 sq cm, aortic peak velocity = 4.0 m/sec and LVEF 60%. CT angio showed minimum diameters of 0.8 x 0.7 cm for right and 0.9 x 1.0 cm for the left common femoral arteries and aortic annulus of 2.2 x 2.8 cm (average 2.5). The STS risk mortality is 2.6% and the Logistic Euroscore mortality is 18.1%. Patient was determined to be extreme risk for surgical AVR due to localized lung cancer with projected life expectancy of 2-3 years. Patient is now planned for CoreValve TAVR (29mm) via percutaneous femoral access under conscious sedation.


Case Presentation


Lorem ipsum dolor sit amet consectetur adipisicing elit. A, dignissimos?